These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15899682)

  • 21. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen.
    Li L; Zhou Y; Bell CJ; Earley MC; Hannon WH; Mei JV
    J Med Screen; 2006; 13(2):79-84. PubMed ID: 16792830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
    Weidler S; Stopsack KH; Hammermann J; Sommerburg O; Mall MA; Hoffmann GF; Kohlmüller D; Okun JG; Macek M; Votava F; Krulišová V; Balaščaková M; Skalická V; Lee-Kirsch MA; Stopsack M
    J Cyst Fibros; 2016 Nov; 15(6):752-758. PubMed ID: 27461140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.
    Sarles J; Barthellemy S; Férec C; Iovanna J; Roussey M; Farriaux JP; Toutain A; Berthelot J; Maurin N; Codet JP; Berthézène P; Dagorn JC
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F118-22. PubMed ID: 10325788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
    Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
    Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five years of experience with biochemical cystic fibrosis newborn screening based on IRT/PAP in Germany.
    Sommerburg O; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Stopsack M; Gahr M; Hoffmann GF; Mall MA
    Pediatr Pulmonol; 2015 Jul; 50(7):655-64. PubMed ID: 25914230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening for cystic fibrosis.
    Hayes D
    South Med J; 2006 Apr; 99(4):403. PubMed ID: 16634253
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers.
    Ellery KM; Kopp B; Conwell DL; Gariepy C
    Pancreas; 2019 Oct; 48(9):1155-1159. PubMed ID: 31593019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.
    Sarles J; Giorgi R; Berthézène P; Munck A; Cheillan D; Dagorn JC; Roussey M
    J Cyst Fibros; 2014 Jul; 13(4):384-90. PubMed ID: 24513262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses.
    Férec C; Verlingue C; Parent P; Morin JF; Codet JP; Rault G; Dagorne M; Lemoigne A; Journel H; Roussey M
    Hum Genet; 1995 Nov; 96(5):542-8. PubMed ID: 8530001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal infection does not affect the immunoreactive trypsinogen screening test for cystic fibrosis.
    Wilson DC; Leslie H; Edgar JD; Halliday HL; Dodge JA
    J Pediatr Gastroenterol Nutr; 1994 Jul; 19(1):97-9. PubMed ID: 7965486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".
    Farrell PM
    Pediatrics; 2004 Jun; 113(6):1811-2. PubMed ID: 15173512
    [No Abstract]   [Full Text] [Related]  

  • 33. Modifying an enzyme immunoassay of immunoreactive trypsinogen to use time-resolved fluorescence.
    Ryall RG; Gjerde EM; Gerace RL; Ranieri E
    Clin Chem; 1993 Feb; 39(2):224-8. PubMed ID: 8432010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    Hammond KB; Abman SH; Sokol RJ; Accurso FJ
    N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Enzyme Immunoassay for Determining Immunoreactive Trypsinogen (IRT) in Dried Blood Spots on Filter Paper Using an Ultra-Microanalytical System.
    Castells Martínez EM; González EC; Tejeda Y; Frómeta A; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Perea Y; Melchor A
    Appl Biochem Biotechnol; 2018 Dec; 186(4):1034-1046. PubMed ID: 29808455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal screening for cystic fibrosis in São Paulo State, Brazil: a pilot study.
    Rodrigues R; Magalhaes PK; Fernandes MI; Gabetta CS; Ribeiro AF; Pedro KP; Valdetaro F; Santos JL; Souza RM; Pazin Filho A; Maciel LM
    Braz J Med Biol Res; 2009 Oct; 42(10):973-8. PubMed ID: 19787152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.
    Ibarra-González I; Campos-Garcia FJ; Herrera-Pérez LDA; Martínez-Cruz P; Moreno-Graciano CM; Contreras-Capetillo SN; León-Burgos V; Maldonado-Solis FA; Alcántara-Ortigoza MA; González Del Angel A; Vela-Amieva M
    J Med Screen; 2018 Sep; 25(3):119-125. PubMed ID: 28992757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study.
    Seror V; Cao C; Roussey M; Giorgi R
    J Med Screen; 2016 Jun; 23(2):62-9. PubMed ID: 26304152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J; Clements B;
    Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening for cystic fibrosis: can one algorithm fit all?
    Caggana M
    Expert Rev Mol Diagn; 2017 Mar; 17(3):205-207. PubMed ID: 28127999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.